[
    {
        "gene_name":"PROM1",
        "genomic_position":"4:15969857-16085324(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22596232"
    },
    {
        "gene_name":"ROM1",
        "genomic_position":"11:62380213-62382592(+)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22596232"
    },
    {
        "gene_name":"FGF1",
        "genomic_position":"5:141971743-142000907(-)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575541"
    },
    {
        "gene_name":"SI",
        "genomic_position":"3:164696686-164796283(-)",
        "cds_mutation":"EXPRESSION",
        "aa_mutation":"EXPRESSION",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:22596232"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Refametinib + Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT01915602"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Refametinib + Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT01915602"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"c.35G>A",
        "aa_mutation":"p.G12D",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Refametinib + Sorafenib",
        "description":null,
        "rs_value":121913529.0,
        "pmid":"PubMed:NCT01915602"
    },
    {
        "gene_name":"FGF19",
        "genomic_position":"11:69513000-69519410(-)",
        "cds_mutation":"Overexpression",
        "aa_mutation":"Overexpression",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575541"
    },
    {
        "gene_name":"BRCA1",
        "genomic_position":"17:41197646-41277500(-)",
        "cds_mutation":"unspecified_or_BRCA2_unspecified",
        "aa_mutation":"unspecified_or_BRCA2_unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":0,
        "response_to_drug":"Sensitivity",
        "therapies":"Temozolomide + Veliparib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT01205828"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Varlitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03499626"
    },
    {
        "gene_name":"AFP",
        "genomic_position":"4:74301880-74321891(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Best supportive care + Ramucirumab",
        "description":null,
        "rs_value":null,
        "pmid":"FDA drug label:NCT02435433"
    },
    {
        "gene_name":"TERT",
        "genomic_position":"5:1253282-1295162(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"RZ001",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT05595473"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Varlitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03499626"
    },
    {
        "gene_name":"ERBB3",
        "genomic_position":"12:56473645-56497289(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Varlitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03499626"
    },
    {
        "gene_name":"ERBB4",
        "genomic_position":"2:212240446-213403565(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Varlitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03499626"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"unspecified_and_KLB_unspecified",
        "aa_mutation":"unspecified_and_KLB_unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.V550L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.V510L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.V510M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.V550M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1648G>T",
        "aa_mutation":"p.V550L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1444G>T",
        "aa_mutation":"p.V482L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1528G>T",
        "aa_mutation":"p.V510L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1444G>A",
        "aa_mutation":"p.V482M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1534T>C",
        "aa_mutation":"p.C512R",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1654T>C",
        "aa_mutation":"p.C552R",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1648G>A",
        "aa_mutation":"p.V550M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1528G>A",
        "aa_mutation":"p.V510M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1648G>C",
        "aa_mutation":"p.V550L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1528G>C",
        "aa_mutation":"p.V510L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1450T>C",
        "aa_mutation":"p.C484R",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.1444G>C",
        "aa_mutation":"p.V482L",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.C552F",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.C512F",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"ALK",
        "genomic_position":"2:29415640-30144432(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Ascrinvacumab",
        "description":null,
        "rs_value":null,
        "pmid":"Unindexed journals, Conference abstracts:NCT01911273"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"rAD-p53",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02418988"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Nivolumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02576509"
    },
    {
        "gene_name":"CD274",
        "genomic_position":"9:5450525-5470547(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Nivolumab",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02576509"
    },
    {
        "gene_name":"NOTCH1",
        "genomic_position":"9:139388896-139440314(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Ginsenoside Rg3 capsule + Pirarubicin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02724358"
    },
    {
        "gene_name":"KIT",
        "genomic_position":"4:55524085-55606881(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Sunitinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT00247676"
    },
    {
        "gene_name":"JAK2",
        "genomic_position":"9:4985245-5128183(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"AZD1480",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT01219543"
    },
    {
        "gene_name":"MET",
        "genomic_position":"7:116312459-116436396(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":2,
        "response_to_drug":"Sensitivity",
        "therapies":"Tivantinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02029157"
    },
    {
        "gene_name":"MET",
        "genomic_position":"7:116312459-116436396(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Tivantinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT02029157"
    }
]